Comments
Loading...

Johnson & Johnson Analyst Ratings

JNJNYSE
Logo brought to you by Benzinga Data
Q1 2025 Earnings in 5 days from now on Tue Apr 15th, before the market open
Conference call scheduled in 5 days at 8:30 AM Click to view the webcast
Consensus Rating1
Buy
Highest Price Target1
$215.00
Lowest Price Target1
$150.00
Consensus Price Target1
$170.68

Johnson & Johnson Analyst Ratings and Price Targets | NYSE:JNJ | Benzinga

Johnson & Johnson Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Johnson & Johnson Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
Dec 24
3
5
Jan
1
1
Feb
3
Mar
3
3
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B of A Securities
Morgan Stanley
Goldman Sachs
RBC Capital
Barclays

1calculated from analyst ratings

Analyst Ratings for Johnson & Johnson

Buy NowGet Alert
04/10/2025Buy NowB of A Securities
Tim Anderson55%
$171 → $159MaintainsNeutralGet Alert
04/09/2025Buy NowMorgan Stanley
Terence Flynn66%
$163 → $164MaintainsEqual-WeightGet Alert
04/09/2025Buy NowGoldman Sachs
Asad Haider 16%
$157 → $172UpgradeNeutral → BuyGet Alert
04/03/2025Buy NowRBC Capital
Shagun Singh53%
$181 → $181ReiteratesOutperform → OutperformGet Alert
04/02/2025Buy NowRBC Capital
Shagun Singh53%
$181 → $181ReiteratesOutperform → OutperformGet Alert
04/02/2025Buy NowGuggenheim
Vamil Divan73%
ReiteratesNeutral → NeutralGet Alert
03/12/2025Buy NowGuggenheim
Vamil Divan73%
ReiteratesNeutral → NeutralGet Alert
03/10/2025Buy NowGuggenheim
Vamil Divan73%
ReiteratesNeutral → NeutralGet Alert
03/05/2025Buy NowB of A Securities
Tim Anderson55%
$159 → $171MaintainsNeutralGet Alert
02/19/2025Buy NowRBC Capital
Shagun Singh53%
$181 → $181ReiteratesOutperform → OutperformGet Alert
02/03/2025Buy NowGuggenheim
Vamil Divan73%
$162 → $166MaintainsNeutralGet Alert
01/28/2025Buy NowBarclays
Matt Miksic66%
$159 → $166MaintainsEqual-WeightGet Alert
01/23/2025Buy NowRBC Capital
Shagun Singh53%
$181 → $181ReiteratesOutperform → OutperformGet Alert
01/23/2025Buy NowMorgan Stanley
Terence Flynn66%
$175 → $163MaintainsEqual-WeightGet Alert
01/23/2025Buy NowStifel
Rick Wise73%
$170 → $155MaintainsHoldGet Alert
01/23/2025Buy NowLeerink Partners
David Risinger73%
$182 → $169MaintainsOutperformGet Alert
01/23/2025Buy NowWells Fargo
Larry Biegelsen67%
$166 → $152MaintainsEqual-WeightGet Alert
01/23/2025Buy NowRaymond James
Jayson Bedford70%
$170 → $165MaintainsOutperformGet Alert
01/23/2025Buy NowB of A Securities
Tim Anderson55%
$160 → $159MaintainsNeutralGet Alert
01/17/2025Buy NowB of A Securities
Tim Anderson55%
$166 → $160MaintainsNeutralGet Alert
12/11/2024Buy NowCitigroup
Joanne Wuensch75%
$185 → $175MaintainsBuyGet Alert
12/10/2024Buy NowB of A Securities
Tim Anderson55%
→ $166Reinstates → NeutralGet Alert
11/15/2024Buy NowWolfe Research
Alexandria Hammond38%
→ $190Initiates → OutperformGet Alert
11/06/2024Buy NowGuggenheim
Vamil Divan73%
$156 → $162MaintainsNeutralGet Alert
10/16/2024Buy NowCitigroup
Joanne Wuensch75%
$180 → $185MaintainsBuyGet Alert
10/16/2024Buy NowWells Fargo
Larry Biegelsen67%
$163 → $166MaintainsEqual-WeightGet Alert
10/16/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/16/2024Buy NowRBC Capital
Shagun Singh53%
$178 → $181MaintainsOutperformGet Alert
10/16/2024Buy NowMorgan Stanley
Terence Flynn66%
$169 → $175MaintainsEqual-WeightGet Alert
10/10/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/08/2024Buy NowRBC Capital
Shagun Singh53%
$175 → $178MaintainsOutperformGet Alert
09/30/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/23/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/20/2024Buy NowRBC Capital
Shagun Singh53%
$175 → $175ReiteratesOutperform → OutperformGet Alert
09/19/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/16/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/09/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/03/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
08/05/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
07/30/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
07/30/2024Buy NowRBC Capital
Shagun Singh53%
$175 → $175ReiteratesOutperform → OutperformGet Alert
07/23/2024Buy NowDaiwa Capital
Narumi Nakagiri23%
$160 → $150DowngradeOutperform → NeutralGet Alert
07/19/2024Buy NowGoldman Sachs
Chris Shibutani55%
$160 → $155MaintainsNeutralGet Alert
07/18/2024Buy NowRBC Capital
Shagun Singh53%
$175 → $175ReiteratesOutperform → OutperformGet Alert
07/18/2024Buy NowTD Cowen
Joshua Jennings52%
$195 → $185MaintainsBuyGet Alert
07/18/2024Buy NowMorgan Stanley
Terence Flynn66%
$167 → $169MaintainsEqual-WeightGet Alert
07/01/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/25/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/20/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy NowRBC Capital
Shagun Singh53%
$175 → $175ReiteratesOutperform → OutperformGet Alert
06/04/2024Buy NowRBC Capital
Shagun Singh53%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/22/2024Buy NowRBC Capital
Shagun Singh53%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/16/2024Buy NowRBC Capital
Shagun Singh53%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/06/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
04/18/2024Buy NowHSBC
Morten Herholdt37%
$169 → $170UpgradeHold → BuyGet Alert
04/17/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
04/17/2024Buy NowMorgan Stanley
Terence Flynn66%
$168 → $167MaintainsEqual-WeightGet Alert
04/17/2024Buy NowRBC Capital
Shagun Singh53%
$181 → $175MaintainsOutperformGet Alert
04/17/2024Buy NowB of A Securities
Geoff Meacham61%
$180 → $170MaintainsNeutralGet Alert
04/15/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
03/13/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
02/28/2024Buy NowRBC Capital
Shagun Singh53%
$181 → $181ReiteratesOutperform → OutperformGet Alert
02/20/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
02/06/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/24/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/24/2024Buy NowRBC Capital
Shagun Singh53%
$181 → $181ReiteratesOutperform → OutperformGet Alert
01/24/2024Buy NowMorgan Stanley
Terence Flynn66%
$170 → $169MaintainsEqual-WeightGet Alert
01/23/2024Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
01/09/2024Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/03/2024Buy NowRaymond James
Jayson Bedford70%
$172 → $175MaintainsOutperformGet Alert
12/13/2023Buy NowWells Fargo
Larry Biegelsen67%
$170 → $163DowngradeOverweight → Equal-WeightGet Alert
12/06/2023Buy NowRBC Capital
Shagun Singh53%
$178 → $181MaintainsOutperformGet Alert
12/01/2023Buy NowRBC Capital
Shagun Singh53%
$178 → $178ReiteratesOutperform → OutperformGet Alert
12/01/2023Buy NowUBS
Danielle Antalffy59%
→ $180UpgradeNeutral → BuyGet Alert
11/20/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
11/17/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
10/23/2023Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/18/2023Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/18/2023Buy NowRaymond James
Jayson Bedford70%
$179 → $172MaintainsOutperformGet Alert
10/18/2023Buy NowMorgan Stanley
Terence Flynn66%
$174 → $171MaintainsEqual-WeightGet Alert
10/12/2023Buy NowBarclays
Matt Miksic66%
$158 → $162MaintainsEqual-WeightGet Alert
10/11/2023Buy NowCantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/11/2023Buy NowMorgan Stanley
Terence Flynn66%
$172 → $174MaintainsEqual-WeightGet Alert
10/09/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
10/05/2023Buy NowRBC Capital
Shagun Singh53%
→ $178Initiates → OutperformGet Alert
10/02/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
09/18/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
09/08/2023Buy NowBarclays
Matt Miksic66%
$175 → $158MaintainsEqual-WeightGet Alert
09/06/2023Buy NowHSBC
Morten Herholdt37%
→ $175Initiates → HoldGet Alert
09/05/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
09/05/2023Buy NowRaymond James
Jayson Bedford70%
$184 → $179MaintainsOutperformGet Alert
08/31/2023Buy NowWells Fargo
Larry Biegelsen67%
$195 → $186MaintainsOverweightGet Alert
08/31/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
08/31/2023Buy NowMorgan Stanley
Terence Flynn66%
$187 → $172MaintainsEqual-WeightGet Alert
08/30/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
08/22/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
08/04/2023Buy NowAtlantic Equities
Steve Chesney56%
$167 → $170MaintainsNeutralGet Alert
07/31/2023Buy NowCantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
07/25/2023Buy NowBarclays
Matt Miksic66%
$171 → $175MaintainsEqual-WeightGet Alert
07/24/2023Buy NowRaymond James
Jayson Bedford70%
$181 → $184MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Johnson & Johnson (JNJ) stock?

A

The latest price target for Johnson & Johnson (NYSE:JNJ) was reported by B of A Securities on April 10, 2025. The analyst firm set a price target for $159.00 expecting JNJ to rise to within 12 months (a possible 8.64% upside). 60 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Johnson & Johnson (JNJ)?

A

The latest analyst rating for Johnson & Johnson (NYSE:JNJ) was provided by B of A Securities, and Johnson & Johnson maintained their neutral rating.

Q

When was the last upgrade for Johnson & Johnson (JNJ)?

A

The last upgrade for Johnson & Johnson happened on April 9, 2025 when Goldman Sachs raised their price target to $172. Goldman Sachs previously had a neutral for Johnson & Johnson.

Q

When was the last downgrade for Johnson & Johnson (JNJ)?

A

The last downgrade for Johnson & Johnson happened on July 23, 2024 when Daiwa Capital changed their price target from $160 to $150 for Johnson & Johnson.

Q

When is the next analyst rating going to be posted or updated for Johnson & Johnson (JNJ)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Johnson & Johnson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Johnson & Johnson was filed on April 10, 2025 so you should expect the next rating to be made available sometime around April 10, 2026.

Q

Is the Analyst Rating Johnson & Johnson (JNJ) correct?

A

While ratings are subjective and will change, the latest Johnson & Johnson (JNJ) rating was a maintained with a price target of $171.00 to $159.00. The current price Johnson & Johnson (JNJ) is trading at is $146.35, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch